Molecular Pathology & Genomics
Unintended consequences
Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.
The evolution of quality assessment
In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.
Blurring boundaries: Ethics and artificial intelligence
With artificial intelligence becoming ever more prominent in biomedical labs and research, biomedical scientist turned ethicist Sarah E Carter looks at the pressing issues.
